International Stem Cell Corporation (ISCO)
OTCMKTS · Delayed Price · Currency is USD
0.1650
-0.0100 (-5.71%)
At close: Feb 5, 2026

International Stem Cell Revenue

International Stem Cell had revenue of $2.37M in the quarter ending September 30, 2025, with 8.72% growth. This brings the company's revenue in the last twelve months to $9.39M, up 10.12% year-over-year. In the year 2024, International Stem Cell had annual revenue of $9.09M with 16.64% growth.

Revenue (ttm)
9.39M
Revenue Growth
+10.12%
P/S Ratio
0.14
Revenue / Employee
293.47K
Employees
32
Market Cap
1.32M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20249.09M1.30M16.64%
Dec 31, 20237.79M-391.00K-4.78%
Dec 31, 20228.18M1.00M13.99%
Dec 31, 20217.18M48.00K0.67%
Dec 31, 20207.13M-2.34M-24.75%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Evofem Biosciences17.73M
Emmaus Life Sciences11.89M
Orgenesis899.00K
Lipella Pharmaceuticals389.78K
Halberd6.94K
Revenue Rankings